Business Wire

Deep Dive Global Canal Rowing Action Concludes World Tour With Fruitful Achievements

24.11.2022 14:22:00 EET | Business Wire | Press release

Share

Covering more than 100 cities in five continents in more than one year, the Deep Dive Global Canal Rowing Action concluded its last leg of the world tour with a global rowing relay in around 20 cities worldwide recently, highlighted the action with fruitful achievements.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221124005072/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Jean-Christophe Rolland, World Rowing Federation president (L3) delivers special honor certificate to Wang Shi (R3), honorary president of Asian Rowing Federation and the action’s team leader in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27) on 14 Nov. 2022. (Photo: Business Wire)

“On the same day, we held great celebrations both in Yangzhou, a major city along the ancient China’s Grand Canal, and in Cairo, one of the most famous cities along the Nile, the longest river worldwide,” said Feng Nan, president of Deep Dive Sports and Health of China and the organizer of the action. “The two cities thousands of kilometers apart, together with other cities participated and witnessed the successful action, making a clear sign that action has won wide endorsement."

The Deep Dive Action, initially co-organized by the World Historic and Cultural Canal Cities Cooperation Organization (WCCO), an international organization headquartered in Yangzhou, and the Shenzhen Foundation for International Exchange and Cooperation (SFIEC) of China, is aiming to promote the idea of sports, health and environmental protection by holding rowing events in canal cities around the world.

“It’s a milestone in the history of rowing. It’s also a great worldwide environmental awareness campaign,” Feng stressed.

Starting from China’s Grand Canal in September 2021, the campaign has been held successfully on the Potomac River in Washington, the Thames in London, the Seine in Paris, the Donau in Vienna, etc., attracting more than 2,000 international paddlers.

Jean-Christophe Rolland, World Rowing Federation president, highly praised the event. “More important was the powerful message carried out by this mission, which connected and inspired the rowing family to make a difference in this regard,” he stated in a signed letter.

At a side event held in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27), Rolland also delivered his appreciation especially to Wang Shi, honorary president of Asian Rowing Federation and the action’s team leader, “It is great to see your incredible environmental advocacy, initiated during your presidency at the Asian Rowing Federation, and continuing since.”

“The action connected different cities and different cultures, and raised environmental awareness of many people under the slogan of ‘zero carbon, zero waste and clean water’,” Feng added, “A new plan of the campaign for the next year is in the pipeline.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Phoebe Liu
deepdive@encyclomedia.cn

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level

Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 09:00:00 EEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 20:07:00 EEST | Press release

Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Helio Strap Pro represents the next evolution of Amazfit's Hybrid Training System, extending performance tracking beyond heart rate to help athletes bett

HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 18:30:00 EEST | Press release

HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye